355 related articles for article (PubMed ID: 17909056)
1. Autocrine glutamate signaling promotes glioma cell invasion.
Lyons SA; Chung WJ; Weaver AK; Ogunrinu T; Sontheimer H
Cancer Res; 2007 Oct; 67(19):9463-71. PubMed ID: 17909056
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signaling.
Suina K; Tsuchihashi K; Yamasaki J; Kamenori S; Shintani S; Hirata Y; Okazaki S; Sampetrean O; Baba E; Akashi K; Mitsuishi Y; Takahashi F; Takahashi K; Saya H; Nagano O
Cancer Sci; 2018 Dec; 109(12):3874-3882. PubMed ID: 30298963
[TBL] [Abstract][Full Text] [Related]
3. Dissection of mitogenic and neurodegenerative actions of cystine and glutamate in malignant gliomas.
Savaskan NE; Seufert S; Hauke J; Tränkle C; Eyüpoglu IY; Hahnen E
Oncogene; 2011 Jan; 30(1):43-53. PubMed ID: 20802520
[TBL] [Abstract][Full Text] [Related]
4. High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells.
Thomas AG; Sattler R; Tendyke K; Loiacono KA; Hansen H; Sahni V; Hashizume Y; Rojas C; Slusher BS
PLoS One; 2015; 10(8):e0127785. PubMed ID: 26252954
[TBL] [Abstract][Full Text] [Related]
5. The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-).
Tsuchihashi K; Okazaki S; Ohmura M; Ishikawa M; Sampetrean O; Onishi N; Wakimoto H; Yoshikawa M; Seishima R; Iwasaki Y; Morikawa T; Abe S; Takao A; Shimizu M; Masuko T; Nagane M; Furnari FB; Akiyama T; Suematsu M; Baba E; Akashi K; Saya H; Nagano O
Cancer Res; 2016 May; 76(10):2954-63. PubMed ID: 26980765
[TBL] [Abstract][Full Text] [Related]
6. Propofol inhibits invasion and proliferation of C6 glioma cells by regulating the Ca
Wang XY; Li YL; Wang HY; Zhu M; Guo D; Wang GL; Gao YT; Yang Z; Li T; Yang CY; Chen YM
Toxicol In Vitro; 2017 Oct; 44():57-65. PubMed ID: 28663055
[TBL] [Abstract][Full Text] [Related]
7. Ca2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation.
Ishiuchi S; Yoshida Y; Sugawara K; Aihara M; Ohtani T; Watanabe T; Saito N; Tsuzuki K; Okado H; Miwa A; Nakazato Y; Ozawa S
J Neurosci; 2007 Jul; 27(30):7987-8001. PubMed ID: 17652589
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma invasion and NMDA receptors: A novel prospect.
Nandakumar DN; Ramaswamy P; Prasad C; Srinivas D; Goswami K
Physiol Int; 2019 Sep; 106(3):250-260. PubMed ID: 31564120
[TBL] [Abstract][Full Text] [Related]
9. Glutamate and the biology of gliomas.
de Groot J; Sontheimer H
Glia; 2011 Aug; 59(8):1181-9. PubMed ID: 21192095
[TBL] [Abstract][Full Text] [Related]
10. Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells.
Ishiuchi S; Tsuzuki K; Yoshida Y; Yamada N; Hagimura N; Okado H; Miwa A; Kurihara H; Nakazato Y; Tamura M; Sasaki T; Ozawa S
Nat Med; 2002 Sep; 8(9):971-8. PubMed ID: 12172541
[TBL] [Abstract][Full Text] [Related]
11. [Glutamate and malignant gliomas, from epilepsia to biological aggressiveness: therapeutic implications].
Blecic S; Rynkowski M; De Witte O; Lefranc F
Bull Cancer; 2013 Sep; 100(9):829-35. PubMed ID: 23883552
[TBL] [Abstract][Full Text] [Related]
12. Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB.
Chung WJ; Sontheimer H
J Neurochem; 2009 Jul; 110(1):182-93. PubMed ID: 19457125
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cystine uptake disrupts the growth of primary brain tumors.
Chung WJ; Lyons SA; Nelson GM; Hamza H; Gladson CL; Gillespie GY; Sontheimer H
J Neurosci; 2005 Aug; 25(31):7101-10. PubMed ID: 16079392
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation.
de Groot JF; Piao Y; Lu L; Fuller GN; Yung WK
J Neurooncol; 2008 Jun; 88(2):121-33. PubMed ID: 18317690
[TBL] [Abstract][Full Text] [Related]
15. AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrix.
Piao Y; Lu L; de Groot J
Neuro Oncol; 2009 Jun; 11(3):260-73. PubMed ID: 18957620
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional modulation of calcium-permeable AMPA receptor subunits in glioblastoma by MEK-ERK1/2 inhibitors and their role in invasion.
Ramaswamy P; Dalavaikodihalli Nanjaiah N; Prasad C; Goswami K
Cell Biol Int; 2020 Mar; 44(3):830-837. PubMed ID: 31814223
[TBL] [Abstract][Full Text] [Related]
17. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties.
Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS
Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells.
Oh MC; Kim JM; Safaee M; Kaur G; Sun MZ; Kaur R; Celli A; Mauro TM; Parsa AT
PLoS One; 2012; 7(10):e47846. PubMed ID: 23110111
[TBL] [Abstract][Full Text] [Related]
19. Combination Therapy with Sulfasalazine and Valproic Acid Promotes Human Glioblastoma Cell Death Through Imbalance of the Intracellular Oxidative Response.
Garcia CG; Kahn SA; Geraldo LHM; Romano I; Domith I; Silva DCLE; Dos Santos Assunção F; Ferreira MJ; Portugal CC; de Souza JM; Romão LF; Netto ADP; Lima FRS; Cossenza M
Mol Neurobiol; 2018 Aug; 55(8):6816-6833. PubMed ID: 29349577
[TBL] [Abstract][Full Text] [Related]
20. Glutamate release by primary brain tumors induces epileptic activity.
Buckingham SC; Campbell SL; Haas BR; Montana V; Robel S; Ogunrinu T; Sontheimer H
Nat Med; 2011 Sep; 17(10):1269-74. PubMed ID: 21909104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
